Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial

BACKGROUND: The early use of broad-spectrum antibiotics remains the cornerstone for the treatment of neonatal late onset sepsis (LOS). However, which antibiotics should be used is still debatable, as relevant studies were conducted more than 20 years ago, recruited in single centres or countries, ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Lutsar, Irja, Chazallon, Corine, Trafojer, Ursula, de Cabre, Vincent Meiffredy, Auriti, Cinzia, Bertaina, Chiara, Calo Carducci, Francesca Ippolita, Canpolat, Fuat Emre, Esposito, Susanna, Fournier, Isabelle, Hallik, Maarja, Heath, Paul T., Ilmoja, Mari-Liis, Iosifidis, Elias, Kuznetsova, Jelena, Meyer, Laurence, Metsvaht, Tuuli, Mitsiakos, George, Pana, Zoi Dorothea, Mosca, Fabio, Pugni, Lorenza, Roilides, Emmanuel, Rossi, Paolo, Sarafidis, Kosmas, Sanchez, Laura, Sharland, Michael, Usonis, Vytautas, Warris, Adilia, Aboulker, Jean-Pierre, Giaquinto, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055900/
https://www.ncbi.nlm.nih.gov/pubmed/32130261
http://dx.doi.org/10.1371/journal.pone.0229380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055900/
https://www.ncbi.nlm.nih.gov/pubmed/32130261
http://dx.doi.org/10.1371/journal.pone.0229380

Ejemplares similares